Pharmacological approaches to retinitis pigmentosa: A laboratory perspective.
about
A Survey of Retinal RemodelingPalmitoylation of Progressive Rod-Cone Degeneration (PRCD) Regulates Protein Stability and LocalizationCombined transplantation of human mesenchymal stem cells and human retinal progenitor cells into the subretinal space of RCS rats.Activation of liver X receptor delayed the retinal degeneration of rd1 mice through modulation of the immunological function of glia.Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations.The bacterial toxin CNF1 as a tool to induce retinal degeneration reminiscent of retinitis pigmentosa.A role of Heat Shock Protein 70 in Photoreceptor Cell Death: Potential as a Novel Therapeutic Target in Retinal Degeneration.Electrical Stimulation as a Means for Improving Vision.The potential of the second sight system bionic eye implant for partial sight restoration.Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.Flavonoid allosteric modulation of mutated visual rhodopsin associated with retinitis pigmentosa.Absence of Sigma 1 Receptor Accelerates Photoreceptor Cell Death in a Murine Model of Retinitis Pigmentosa.HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.N-methyl-N-nitrosourea induces retinal degeneration in the rat via the inhibition of NF-κB activation.TNFa knockdown in the retina promotes cone survival in a mouse model of autosomal dominant retinitis pigmentosa.Systemic inflammatory immune signatures in a patient with CRB1 linked retinal dystrophy.New Experimental Models of Retinal Degeneration for Screening Molecular Photochromic Ion Channel Blockers.
P2860
Q26771531-04C9A47A-A272-4499-9B75-B6540269B4D9Q28854592-30BF2242-587B-4708-8FA0-0C2E89DB3682Q33670069-D1A24076-F4A4-49A2-803B-F8AD5E7E452FQ33762016-897311EE-C656-4405-BA3D-BAC0D41B7716Q37275303-6805992A-3710-4ABC-BC72-CB3BE2C61C1BQ37360429-1666575E-2B0D-4E6C-87A3-C4F035B02AFAQ38617618-6D274FB1-734A-473F-8302-8C227C7E4768Q38803756-046B8E9C-2794-42FD-BF3C-E7C3255D60A4Q38849925-A8E10F1E-C8BE-4754-BC10-D36A9567B279Q38880061-B42A3B2A-035B-42D6-B7CD-741E35B26569Q41330115-316F2E8C-B2E7-42D8-9583-8F2FAADE4ACEQ41632430-A91646BB-B408-4A40-B03A-8630A23D79B3Q42358229-B9CD99C3-AB77-4336-8BD3-42F5E18B3744Q51318819-AF930649-D3D6-4678-9E4B-599B63E980E9Q51384291-5CFE5E77-C925-4B07-BFCD-7965FBF021F0Q51444246-39121C7C-EA76-4B96-8E53-0D7E0E69594CQ55379623-1F541212-4D26-4970-BD0A-68B976064286
P2860
Pharmacological approaches to retinitis pigmentosa: A laboratory perspective.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacological approaches to retinitis pigmentosa: A laboratory perspective.
@en
type
label
Pharmacological approaches to retinitis pigmentosa: A laboratory perspective.
@en
prefLabel
Pharmacological approaches to retinitis pigmentosa: A laboratory perspective.
@en
P50
P1476
Pharmacological approaches to retinitis pigmentosa: A laboratory perspective.
@en
P2093
Elena Novelli
Viviana Guadagni
P356
10.1016/J.PRETEYERES.2015.06.005
P577
2015-06-22T00:00:00Z